Kazia Therapeutics Limite...

0.81
-0.05 (-5.81%)
At close: Mar 03, 2025, 3:58 PM
0.81
0.00%
After-hours: Mar 03, 2025, 04:05 PM EST

Kazia Therapeutics Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY03 FY02 FY01 FY00 FY99
Net Income -26.78M -20.46M -24.65M -8.42M -12.47M -10.27M -6.04M -10.67M -12.15M -7.31M -7.57M -784.56K -1.34M -9.48M -15.25M -23.79M -24.76M -24.29M -17.92M -12.23M -12.5M -10.63M -14.68M -42.65M 21.73M -17.08M
Depreciation & Amortization 1.87M 1.87M 1.95M 1.27M 1.08M 1.08M 1.55M 1.41M 643K 574.96K 572.14K 336.18K 25K 83K 198K 282K 353.28K 976.21K 1.39M 1.62M 1.71M 1.88M 1.85M n/a n/a 1.35M
Stock-Based Compensation 533K 1.16M 1.68M 637K 262K 246K 165K 517K 372K n/a n/a 401.55K 574K 651K 728K 1.2M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital 10M 584.09K -98K -392K 1.31M -472K -188K -230K -730K 1.18M 129.86K -3.37M 1.03M 1.94M 390K -836K 2.43M 539.98K -474.36K -536.4K 1.82M 1.19M 895.2K n/a n/a 449.41K
Other Non-Cash Items 4.79M -1.75M -1.64M -1.95M 474K 62K -9.84M 1.33M 100K -124.39K 813.88K -4.86M -7K -3.25M -2.91M -23.79M -87.8K 3.66M 881.34K n/a 461.99K -11.87K 493.78K 3.95M -43.38M 599.21K
Deferred Income Tax n/a n/a n/a 4.39M 168K 1.81M 3.97M 3.51M -225K n/a n/a -541.83K 9K 2.98M 2.9M 23.82M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital 10M 4.03M -104K -5.03M 1.67M 353K 1.54M -4.02M -715K 1.1M 473.37K -3.34M 1.39M 307K -2.28M 1.67M 4.4M 5.03M 1.21M -2.14M -145.89K 2.93M 5.65M 4.52M 2.9M -5.84M
Operating Cash Flow -9.58M -15.16M -22.76M -9.11M -8.81M -6.71M -8.66M -11.43M -11.98M -5.76M -5.71M -8.79M 643K -8.7M -16.61M -20.6M -20.1M -14.63M -14.44M -12.76M -10.48M -5.83M -6.68M -34.18M -18.75M -20.97M
Capital Expenditures n/a n/a n/a n/a n/a n/a n/a -11.65K -525K -97.47K -26.98K -10.15K -1K -56K -22K -94K -95.11K -299.47K -319.39K -754.1K -709.43K -755.42K n/a -1.87M -2.69M -4.94M
Acquisitions n/a n/a -2.37M n/a n/a n/a n/a -7.1M n/a n/a n/a 31.67K 7.99M n/a n/a n/a n/a n/a n/a n/a n/a n/a -143.87K n/a n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a 2.36M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a 268.00 n/a n/a 2.36M 150K -8.6K 3K 7.79K n/a 150K -7.99M 343K 12K 5K 3.83M 261.74K 9.43K n/a 78.67K 34.13K 39.08K 331.18K 113.89K n/a
Investing Cash Flow n/a n/a -2.36M n/a n/a 2.36M 150K -7.12M -522K -89.68K -26.98K 171.52K 6K 287K -10K -89K 3.73M -37.73K -309.95K -754.1K -630.77K -721.28K -104.8K -1.54M -2.58M -4.94M
Debt Repayment 405K n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.5M n/a n/a n/a n/a 2M n/a -15.33K -750.62K -839.35K -675.11K -841.5K -740.68K -885.75K 1.82M -1.2M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3.33M n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies n/a -3 3.73K -152 1K n/a n/a -18K -71K -2.94M n/a -157K n/a n/a n/a n/a -2M n/a 0.20 -0.8 0.32 0.04 -1.93M 0.76 n/a n/a
Financial Cash Flow 5.99M 12.97M 3.73M 28.11M 12.14M 3.82M n/a -17.66K 782K 47.41M 5.5M 3.01M 1.75M 763K n/a 11.56M 16.95M 24.9M 4.04K 6.1M 37.05M 129.12K 16.08M 40.16M 19.95M 40.75M
Net Cash Flow -3.58M -2.12M -20.23M 18.82M 3.33M -522K -8.5M -19M -10.92M 41.87M -236.31K -5.61M 2.33M -8.37M -18.21M -2.05M -4.12M 8M -13.6M -11.27M 27.24M -8.88M 8.81M 4.52M -1.16M 14.83M
Free Cash Flow -9.58M -15.16M -22.76M -9.11M -8.81M -6.71M -8.66M -11.45M -12.51M -5.86M -5.74M -8.8M 642K -8.76M -16.63M -20.7M -20.19M -14.92M -14.76M -13.51M -11.19M -6.59M -6.68M -36.05M -21.45M -25.92M